Literature DB >> 30957671

Clinical-pathological characteristics and short-term follow-up associated with proliferation, apoptosis and angiogenesis in a prospective cohort of patients with colorectal tumours.

Maximino Redondo1, Cristina Abitei2, Teresa Téllez1, Rafael Fúnez2, Teresa Pereda2, Isabel Rodrigo2, Ana M Betancourt2, Marilina García-Aranda1, Antonio Rueda1,3, Rafael Cayetano Martínez García4, María Manuela Morales Suarez-Varela5, Iñaki Zabalza6, Matilde Sánchez Del Charco7, Juan José Borrero Martín8, Raimundo García Del Moral9, Antonio Escobar10, JoséMaría Quintana11, Francisco Rivas-Ruiz1.   

Abstract

We investigate the clinical and pathological features related to variations in colorectal tumour apoptosis, proliferation and angiogenesis and the influence of the latter in short-term mortality (2 years); 551 tumour samples from a prospective cohort of patients with colorectal cancer were examined and tumour biology markers were determined as follows: percentage of apoptotic cells, by the terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling technique; Ki-67 antigen, as a cell proliferation marker and density of microvessels (as a marker of angiogenesis). An increase in the percentage of cellular apoptosis is significantly related to the presence of poorly differentiated tumours, with vascular invasion (p < 0.001). The CD105 angiogenesis marker is not related to any clinical-pathological parameter except that of higher frequency in older patients (p = 0.03). Ki-67 is more frequently expressed in tumours with less nervous invasion (p = 0.05). Neither apoptosis nor angiogenesis present any significant association with short-term survival. The only marker clearly related to 2-year survival is Ki-67, which is shown to be a good prognostic factor in the multivariate analysis (hazard ratio = 0.49; 95% confidence interval = 0.27-0.90). Therefore, in a prospective cohort of colorectal cancer patients, only Ki-67 is a marker of good prognosis in short-term follow-up.

Entities:  

Keywords:  Cell proliferation; Ki-67 marker; angiogenesis; apoptosis; colorectal neoplasms

Mesh:

Substances:

Year:  2019        PMID: 30957671     DOI: 10.1177/1010428319835684

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  1 in total

Review 1.  Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review.

Authors:  Daniel Sur; Andrei Havasi; Cristian Virgil Lungulescu; Simona Ruxandra Volovat; Claudia Burz; Alexandru Irimie
Journal:  Med Pharm Rep       Date:  2022-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.